PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-05-03

Date Title Company
03-May-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
03-May-2022 miDiagnostics launches its CE-IVD certified ultra-fast COVID-19 PCR test miDiagnostics
03-May-2022 Horizon Therapeutics plc Receives European Commission (EC) Approval of UPLIZNA® (inebilizumab) for the Treatment of Adults with Neuromyelitis Optica Spectrum Disorder (NMOSD) Horizon Therapeutics
03-May-2022 Publication of Annual Report and Financial Statements for the Year ended 31 December 2021 Acacia Pharma Group
03-May-2022 Coronavirus jams communication signals to immune cells in the gut The Earlham Institute
03-May-2022 Europe’s first dual orexin receptor antagonist – QUVIVIQ (daridorexant) – granted approval to improve both nighttime symptoms and daytime functioning in adults with chronic insomnia disorder Idorsia
03-May-2022 Ipsen: European Commission Approves Cabometyx® as a Second-Line Treatment for People Living With Radioactive Iodine-Refractory Differentiated Thyroid Cancer Businesswire
03-May-2022 Deenova Launches First Ever, Pay-Per-Dose Unit Dose Pharmacy Automation Service in England Businesswire
03-May-2022 AdBio partners welcomes Inserm Transfert as investor in second fund – AFB Fund II Andrew Lloyd Associates
03-May-2022 Ipsen : La Commission européenne approuve Cabometyx® comme traitement de deuxième ligne dans le cancer de la thyroïde différencié réfractaire à l’iode radioactif Businesswire
03-May-2022 Isorg appoints Dieter May as new CEO Andrew Lloyd Associates
03-May-2022 Fructosamine Reagents Market COVID-19 Industry Analysis, Future Trends, Opportunity Growth, Regional Outlook and Forecast 2029 MARKITWIRED
03-May-2022 Magnesium Testing Reagents Market Insights, New Innovations, Research and Growth Factor till 2029 MARKITWIRED
03-May-2022 Ammonia Testing Market Growth Analysis, Opportunities, Trends, Developments, And Forecast to 2029 MARKITWIRED
03-May-2022 Cardiac Ultrasound Systems Market is forecast to register 5% CAGR between 2021 and 2031 MARKITWIRED
03-May-2022 Global Narcolepsy Treatment Market is projected to stand at a valuation of US$ 6.67 Billion, registering an annual growth rate of 5.7 percent, from 2022-2028. MARKITWIRED
03-May-2022 MRI Guided Neurosurgical Ablation Market is projected to reach US$ 216.3 Million by 2028 MARKITWIRED
03-May-2022 Membrane Microfiltration Market to reach a value of US$ 8,048.5 Million By 2028 MARKITWIRED
03-May-2022 MIMETAS Expands Adult Stem Cell Organoid License to All Organs B3C newswire
03-May-2022 Watson-Marlow Fluid Technology Solutions and the National Institute for Bioprocessing Research and Training partner for biopharma training programme Sciad Newswire